Cedric Francois insider trades: Apellis Pharmaceuticals (APLS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cedric reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | APLS | ↓ Sell | 27,192 | $21.77 | $592K | Direct | Jan 23, 2026 (1d) |
| Jan 20, 2026 | APLS | ↓ Sell | 8,182 | $19.79 | $162K | Direct | Jan 21, 2026 (1d) |
| Jan 13, 2026 | APLS | ↓ Sell | 10,186 | $22.19 | $226K | Direct | Jan 15, 2026 (2d) |
| Aug 28, 2025 | APLS | ↓ Sell | 225,000 | $28.23 | $6.4M | Indirect Owner (The Cedric Francois Irre | Aug 29, 2025 (1d) |
| Jul 17, 2025 | APLS | ↓ Sell | 19,725 | $20.21 | $399K | Direct | Jul 18, 2025 (1d) |
| Jul 15, 2025 | APLS | ↓ Sell | 139,365 | $20.19 | $2.8M | Direct | Jul 16, 2025 (1d) |
| Jan 29, 2025 | APLS | ↓ Sell | 2,824 | $29.52 | $83K | Direct | Jan 30, 2025 (1d) |
| Jan 22, 2025 | APLS | ↓ Sell | 13,551 | $30.43 | $412K | Direct | Jan 23, 2025 (1d) |
| Jan 17, 2025 | APLS | ↓ Sell | 6,007 | $29.96 | $180K | Direct | Jan 21, 2025 (4d) |
| Jan 13, 2025 | APLS | ↓ Sell | 6,247 | $28.70 | $179K | Direct | Jan 14, 2025 (1d) |
| Mar 1, 2024 | APLS | ↓ Sell | 250,000 | $64.11 | $16.0M | Direct | Mar 5, 2024 (4d) |
| Feb 12, 2024 | APLS | ↓ Sell | 3,962 | $67.77 | $268K | Direct | Feb 13, 2024 (1d) |
| Jan 29, 2024 | APLS | ↓ Sell | 2,843 | $64.14 | $182K | Direct | Jan 31, 2024 (2d) |
| Jan 22, 2024 | APLS | ↓ Sell | 13,431 | $65.00 | $873K | Direct | Jan 23, 2024 (1d) |
| Jan 16, 2024 | APLS | ↓ Sell | 7,851 | $66.81 | $525K | Direct | Jan 17, 2024 (1d) |
| Nov 21, 2023 | APLS | ↓ Sell | 5,000 | $48.80 | $244K | Direct | Nov 21, 2023 (0d) |
| Sep 1, 2023 | APLS | ↓ Sell | 150,000 | $41.75 | $6.3M | Direct | Sep 1, 2023 (0d) |
| May 16, 2023 | APLS | ↓ Sell | 30,000 | $85.66 | $2.6M | Direct | May 18, 2023 (2d) |
| Apr 18, 2023 | APLS | ↓ Sell | 30,000 | $82.02 | $2.5M | Direct | Apr 20, 2023 (2d) |
| Mar 21, 2023 | APLS | ↓ Sell | 30,000 | $62.74 | $1.9M | Direct | Mar 23, 2023 (2d) |
| Dec 19, 2022 | APLS | ↓ Sell | 28,200 | $52.06 | $1.5M | Direct | Dec 21, 2022 (2d) |
| Dec 15, 2020 | APLS | ↓ Sell | 5,000 | $52.16 | $261K | Direct | Dec 16, 2020 (1d) |
| Nov 16, 2020 | APLS | ↓ Sell | 5,000 | $39.38 | $197K | Direct | Nov 17, 2020 (1d) |
| Oct 15, 2020 | APLS | ↓ Sell | 5,000 | $34.46 | $172K | Direct | Oct 16, 2020 (1d) |
| Sep 15, 2020 | APLS | ↓ Sell | 5,000 | $30.96 | $155K | Direct | Sep 16, 2020 (1d) |
| Aug 20, 2020 | APLS | ↓ Sell | 3,457 | $30.00 | $104K | Direct | Aug 21, 2020 (1d) |
| Aug 18, 2020 | APLS | ↓ Sell | 1,543 | $30.00 | $46K | Direct | Aug 20, 2020 (2d) |
| Jul 15, 2020 | APLS | ↓ Sell | 5,000 | $32.12 | $161K | Direct | Jul 16, 2020 (1d) |
| Jun 15, 2020 | APLS | ↓ Sell | 5,000 | $30.21 | $151K | Direct | Jun 16, 2020 (1d) |
| May 15, 2020 | APLS | ↓ Sell | 5,000 | $29.92 | $150K | Direct | May 19, 2020 (4d) |
| Apr 15, 2020 | APLS | ↓ Sell | 5,000 | $29.77 | $149K | Direct | Apr 17, 2020 (2d) |
| Mar 16, 2020 | APLS | ↓ Sell | 35,637 | $21.32 | $760K | Direct | Mar 18, 2020 (2d) |
| Feb 18, 2020 | APLS | ↓ Sell | 35,637 | $40.66 | $1.4M | Direct | Feb 20, 2020 (2d) |
| Jan 15, 2020 | APLS | ↓ Sell | 35,638 | $42.11 | $1.5M | Direct | Jan 17, 2020 (2d) |
| Dec 16, 2019 | APLS | ↓ Sell | 5,000 | $27.95 | $140K | Direct | Dec 17, 2019 (1d) |
| Nov 15, 2019 | APLS | ↓ Sell | 5,000 | $27.28 | $136K | Direct | Nov 18, 2019 (3d) |
| Oct 15, 2019 | APLS | ↓ Sell | 5,000 | $26.31 | $132K | Direct | Oct 16, 2019 (1d) |
| Sep 16, 2019 | APLS | ↓ Sell | 5,000 | $26.59 | $133K | Direct | Sep 17, 2019 (1d) |
| Aug 15, 2019 | APLS | ↓ Sell | 10,000 | $26.80 | $268K | Direct | Aug 16, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other APLS insiders
Open-market trades in the last 12 months
About Cedric Francois's insider trades
Cedric Francois is Chief Executive Officer at Apellis Pharmaceuticals (APLS). Since Aug 15, 2019, Cedric has reported no open-market purchases and 39 sales worth $50.2M on SEC Form 4. In the last 12 months: 3 sales ($980K).
Their filings also include option exercises (20 filings), grants and awards (12 filings), shares withheld for taxes (7 filings), other transactions (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.